Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Shares, without par value
-
Shares outstanding
-
7,011,892
-
Total 13F shares
-
110,826
-
Share change
-
+110,798
-
Total reported value
-
$507,030
-
Price per share
-
$4.57
-
Number of holders
-
18
-
Value change
-
+$506,902
-
Number of buys
-
17
Institutional Holders of Edesa Biotech, Inc. - Common Shares, without par value (EDSA) as of Q4 2023
As of 31 Dec 2023,
Edesa Biotech, Inc. - Common Shares, without par value (EDSA) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
110,826 shares.
The largest 10 holders included
CM Management, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, DIMENSIONAL FUND ADVISORS LP, UBS Group AG, Tower Research Capital LLC (TRC), ROYAL BANK OF CANADA, TD Waterhouse Canada Inc., FIFTH THIRD BANCORP, and BlackRock Inc..
This page lists
19
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.